U.S. markets open in 7 hours 56 minutes

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.42000.0000 (0.00%)
At close: 04:00PM EDT
2.3700 -0.05 (-2.07%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close2.4200
Bid0.0000 x 800
Ask0.0000 x 1800
Day's Range2.3800 - 2.4550
52 Week Range1.7950 - 4.5000
Avg. Volume840,904
Market Cap317.775M
Beta (5Y Monthly)1.42
PE Ratio (TTM)30.25
EPS (TTM)0.0800
Earnings DateNov 07, 2023 - Nov 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-9% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ORGO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Organogenesis Holdings Inc.
    ORGO: What does Argus have to say about ORGO?ORGANOGENESIS HOLDINGS INC has an Investment Rating of SELL; a target price of $2.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more
  • GlobeNewswire

    Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

    CANTON, Mass. , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that company management will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from Septemb

  • Motley Fool

    Why Shares of Organogenesis Holdings Are Dropping Thursday

    Shares of Organogenesis Holdings (NASDAQ: ORGO) were down more than 19% as of 11 a.m. on Thursday after the company announced second-quarter earnings and withdrew annual guidance after the markets closed on Wednesday. Organogenesis is a healthcare company that makes advanced care products for the wound-healing process. The company operates in two segments, Advanced Wound Care and Surgical & Sports Medicine, and both saw declines.

  • Thomson Reuters StreetEvents

    Q2 2023 Organogenesis Holdings Inc Earnings Call

    Q2 2023 Organogenesis Holdings Inc Earnings Call